Abstract
The clinical relevance of the distinction between short- and long-acting benzodiazepine anxiolytics is discussed, and emphasis is placed on the persistence of these drugs' effects on functioning throughout a course of treatment. Nootropics (drugs that might benefit driving in older adults) are discussed. However, the evidence that any drug produces such positive benefits is currently weak.